Introduction
With the rise of GLP-1 medications such as Ozempic, Wegovy and Mounjaro, many patients are asking whether these medications can be combined with bariatric surgery. Can GLP-1 medications help with pre-op preparation? Should they be used after surgery? What should you watch out for?
As Op. Dr. Mustafa Erol, with more than 35 years of surgical experience and over 8,000 bariatric procedures, I am seeing a growing number of patients who have tried GLP-1 before surgery and also more patients raising these medications after surgery.
In this guide we cover the role of GLP-1 medications in bariatric care — before surgery, after surgery and alongside surgery.
Understanding GLP-1 Medications
What Are GLP-1 Agonists?
GLP-1 (glucagon-like peptide-1) agonists are medications that:
- Mimic a natural hormone released after eating
- Reduce appetite and increase the feeling of fullness
- Slow stomach emptying
- Improve blood sugar control
- Support weight loss
Common GLP-1 Medications
| Medication | Active Ingredient | Use for Weight Loss |
|---|---|---|
| Ozempic | Semaglutide | Off-label (diabetes medication) |
| Wegovy | Semaglutide (high dose) | FDA-approved for weight loss |
| Mounjaro | Tirzepatide | Off-label / approval pending |
| Saxenda | Liraglutide | FDA-approved for weight loss |
The Weight Loss Effect
GLP-1 medications:
GLP-1 Medications BEFORE Surgery
Pre-Op Use: A Growing Trend
Some surgeons now use GLP-1 before surgery to:
- Shrink the Liver:
- Fatty liver is common in obese patients
- A large liver complicates surgery
- GLP-1 can help shrink the liver
- Surgical access becomes safer
- Pre-Op Weight Loss:
- Initial loss before surgery
- Reduced surgical risk
- Technically easier operation
- Demonstration of commitment
- Blood Sugar Optimization:
- Better diabetes control before surgery
- Reduced perioperative risk
- Improved wound healing
Potential Benefits
| Benefit | Explanation |
|---|---|
| Safer surgery | Less weight = less surgical risk |
| Easier surgery | Smaller liver, less intra-abdominal fat |
| Better outcomes | A healthier starting point |
| Proving commitment | Shows the patient's capacity for change |
Considerations
- Slowed Stomach Emptying:
- GLP-1 medications slow gastric emptying
- May increase aspiration risk during anaesthesia
- Many surgeons stop GLP-1 1-2 weeks before surgery
- Protocols vary by surgeon and institution
- Cost:
- GLP-1 medications are expensive
- Insurance coverage varies
- May not be cost-effective in the short term
- Is it required?
- The traditional pre-op diet (2-4 weeks) works well
- GLP-1 can complicate the process
- Not every patient needs pre-op medication
Current Practice
Most surgeons recommend:
GLP-1 Medications AFTER Surgery
Post-Op Use: Emerging Practices
After bariatric surgery, GLP-1 medications may come up for:
- Weight Regain:
- When patients regain significant weight
- When the effect of surgery diminishes
- To re-accelerate weight loss
- Inadequate Weight Loss:
- When surgery alone does not reach the goal
- Alongside the surgical tool
- When revision surgery is not preferred
- Diabetes Management:
- For ongoing diabetes after surgery
- For additional blood sugar control
- For metabolic support
Research Data
Studies on post-op GLP-1 use show:
| Finding | Detail |
|---|---|
| Additional weight loss | Some studies show 5-15% additional loss |
| Improved diabetes control | Stronger metabolic effect |
| Generally well tolerated | Side effects similar to non-surgical patients |
| Short-term data | Long-term outcomes still being studied |
Situations Where It May Help
- After Sleeve Gastrectomy:
- Sleeve patients may benefit more from adding GLP-1
- Sleeve does not affect intestinal hormones as much as bypass
- GLP-1 fills this hormonal gap
- For Weight Regain:
- If regain is from increased hunger
- If portion sizes have grown
- If behavioural interventions have not been enough
- Instead of Revision Surgery:
- Less invasive than reoperation
- Can provide the additional loss needed
- Lower risk than revision
Considerations
- Cost:
- An ongoing medication expense
- May require indefinite continuation
- Insurance coverage varies
- Side Effects:
- Nausea (may be more pronounced with a smaller stomach)
- Gastrointestinal issues
- Potential post-op interactions
- Long-Term Unknowns:
- Post-op use data is limited
- Long-term safety in surgical anatomy is not fully known
- More research is needed
GLP-1 vs. Surgery: A Comparison
Amount of Weight Loss
| Approach | Average Weight Loss |
|---|---|
| GLP-1 alone | 15-22% of total body weight |
| Sleeve Gastrectomy | 25-30% of total body weight |
| Gastric Bypass | 30-35% of total body weight |
| Surgery + GLP-1 | Effect may be additive |
Sustainability
- GLP-1 Alone:
- Weight is usually regained when the medication is stopped
- Continuous use is needed for ongoing effect
- An ongoing cost burden
- Surgery:
- Permanent anatomical change
- Weight loss is maintained long-term
- No ongoing medication costs beyond the surgical cost
- Combined Approach:
- Surgery provides a permanent foundation
- GLP-1 can boost results or support maintenance
- May allow lower medication doses
Cost-Effectiveness
| Factor | GLP-1 | Surgery | Combined |
|---|---|---|---|
| Upfront cost | Low | High | Higher |
| Ongoing cost | High (significant annual expense) | Low | Moderate |
| 10-year total | Very high | Lower | Moderate |
| Permanence | Requires continuous use | Permanent | Variable |
Practical Considerations
If You Are Using GLP-1 and Considering Surgery
- Questions to Ask:
- How long before surgery should I stop?
- Will I need the medication after surgery?
- What is the specific protocol for the medication I am taking?
- How does this affect my surgical risk?
- Typical Approach:
- Stop GLP-1 1-2 weeks before surgery
- Follow the standard pre-op diet
- Surgery as planned
- Evaluation of GLP-1 need based on post-op results
If You Have Had Surgery and Are Considering GLP-1
- Situations to Consider:
- Significant weight regain (about 10+ kg)
- A long-term plateau above goal
- Persistent diabetes
- Increasing hunger/appetite
- Steps:
- Consult your bariatric surgeon
- Evaluate whether nutritional/behavioural changes can help
- Consider a GLP-1 trial if appropriate
- Monitor response and adjust dose
If You Are Torn Between the Two Options
- Surgery May Be More Suitable When:
- BMI > 40 (or > 35 with co-existing disease)
- You prefer a long-term solution
- You want to avoid ongoing medication use
- You can afford the cost of surgery
- You have significant co-existing diseases that need to be resolved
- GLP-1 May Be More Suitable When:
- BMI is 27-35
- You are not yet ready for surgery
- You prefer a non-surgical approach
- You accept indefinite medication use
- You have insurance coverage for medication
The Future: Integrated Treatment
A New Paradigm
The future of obesity treatment may include:
- GLP-1 as a bridge to surgery (pre-op optimization)
- Surgery as the primary intervention
- GLP-1 for post-op maintenance if needed
- A personalized approach based on response
Individualized Care
The same approach does not apply to every patient:
| Patient Profile | Possible Strategy |
|---|---|
| BMI 35-40, good metabolic health | Success with GLP-1 alone is possible |
| BMI 40+, co-existing diseases | Surgery is probably optimal |
| Post-op weight regain | Adding GLP-1 may help |
| Failure to reach surgical goal | A combined approach may be considered |
What Research Shows
Ongoing studies are examining:
Our Approach
Personalized Recommendations
In our clinic:
- We evaluate every patient individually
- We consider all treatment options
- We do not see surgery and medication as alternatives to one another
- We recommend what is most appropriate for your situation
Honest Guidance
We believe in transparent conversation:
- If GLP-1 alone can work, we say so clearly
- If surgery is more appropriate, we explain why
- If combination makes sense, we discuss it
- Our recommendations are guided by your health interests
Frequently Asked Questions
Can I continue Ozempic until my surgery date?
Most surgeons recommend stopping GLP-1 1-2 weeks before surgery due to slowed stomach emptying that can increase aspiration risk during anaesthesia. Follow your surgeon's specific protocol. Do not stop the medication without consulting your healthcare team.
Will I be on GLP-1 after bariatric surgery?
Most patients do not need GLP-1 after successful bariatric surgery; the operation already produces similar hormonal effects. However, some patients with weight regain or persistent diabetes may benefit. This is evaluated individually.
Is GLP-1 safe with an altered post-op stomach?
Early data suggests GLP-1 is generally well tolerated after bariatric surgery; however, side effects such as nausea may be more pronounced with a smaller stomach. Long-term safety data specific to this patient group is limited. Use should be managed by clinicians experienced with both bariatric surgery and GLP-1.
Why have surgery if GLP-1 works?
If GLP-1 helps you reach your goals and you accept indefinite use, surgery may not be necessary. However, consider: GLP-1 requires ongoing use and cost; weight usually returns when stopped; surgery provides permanent change. Your BMI, co-existing diseases and personal preferences determine the right answer.
Does GLP-1 help with loose skin or other post-op issues?
No. GLP-1 affects weight; it does not address loose skin, nutritional deficiencies or other post-op issues. It can help with weight maintenance or additional loss, which may reduce some loose skin formation. But it is not a treatment for existing loose skin.
The Right Treatment for You
The field of obesity treatment is evolving rapidly. GLP-1 medications have added a powerful option to our toolkit; their role in bariatric care — before surgery, after surgery or instead of surgery — is still being defined.
The most important thing is finding the approach that fits your individual situation.
Let Us Discuss Your Options
Whether you are considering surgery, already using GLP-1 or exploring your options:
- Phone/WhatsApp: +90 532 293 99 39
- Email: info@doktormustafaerol.com
*This content is for educational purposes only. Make medication decisions with your healthcare team.*